In patients with ovarian and breast cancer receiving platinum‐based adjuvant chemotherapy, patients lacking BRCA locus‐specific LOH had significantly worse OS than those with BRCA2 homozygous deletion.27, 28. Here, BRCA2 is linked to breast carcinoma.